Published in Antioxid Redox Signal on October 28, 2010
Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood (2013) 1.07
Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem (2011) 1.03
Using quantitative redox proteomics to dissect the yeast redoxome. J Biol Chem (2011) 0.96
Targeting allosteric disulphide bonds in cancer. Nat Rev Cancer (2013) 0.96
The cyclic cystine ladder in θ-defensins is important for structure and stability, but not antibacterial activity. J Biol Chem (2013) 0.82
Do vicinal disulfide bridges mediate functionally important redox transformations in proteins? Antioxid Redox Signal (2013) 0.79
Thiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment. Annu Rev Chem Biomol Eng (2016) 0.75
Reactivity of disulfide bonds is markedly affected by structure and environment: implications for protein modification and stability. Sci Rep (2016) 0.75
Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE. J Biol Chem (2016) 0.75
Redox Status of β2GPI in Different Stages of Diabetic Angiopathy. Dis Markers (2016) 0.75
Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation. PLoS One (2016) 0.75
From structure to redox: the diverse functional roles of disulfides and implications in disease. Proteomics (2017) 0.75
Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A (2006) 2.65
Allosteric disulfide bonds. Biochemistry (2006) 2.32
Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol (2002) 2.28
Orchestrated intron retention regulates normal granulocyte differentiation. Cell (2013) 2.06
Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry (2006) 1.99
Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A (2003) 1.86
Arsenical-based cancer drugs. Cancer Treat Rev (2007) 1.78
Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol Cell Biol (2003) 1.44
Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood (2013) 1.19
Post-translational control of protein function by disulfide bond cleavage. Antioxid Redox Signal (2013) 1.18
Cross-strand disulphides in cell entry proteins: poised to act. Bioessays (2004) 1.15
Search for allosteric disulfide bonds in NMR structures. BMC Struct Biol (2007) 1.15
Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. Blood (2003) 1.10
Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice. J Biol Chem (2004) 1.05
Critical importance of the cell system when studying tissue factor de-encryption. Blood (2008) 1.04
Mitochondria as cancer drug targets. Trends Mol Med (2004) 1.04
Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood (2013) 1.04
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer Cell (2003) 1.03
BloodChIP: a database of comparative genome-wide transcription factor binding profiles in human blood cells. Nucleic Acids Res (2013) 1.03
Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. J Immunol (2006) 1.01
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood (2010) 0.99
Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol (2008) 0.98
The von Willebrand factor-reducing activity of thrombospondin-1 is located in the calcium-binding/C-terminal sequence and requires a free thiol at position 974. Blood (2002) 0.97
Noninvasive imaging of cell death using an Hsp90 ligand. J Am Chem Soc (2011) 0.96
Redox control on the cell surface: implications for HIV-1 entry. Antioxid Redox Signal (2003) 0.96
Disulfide bond acquisition through eukaryotic protein evolution. Mol Biol Evol (2010) 0.95
Control of blood proteins by functional disulfide bonds. Blood (2014) 0.94
Redox properties of the tissue factor Cys186-Cys209 disulfide bond. Biochem J (2011) 0.93
Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain. Blood (2011) 0.93
Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes. J Biol Chem (2011) 0.92
Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin. J Biol Chem (2010) 0.92
Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol. J Med Chem (2009) 0.91
Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. Biochim Biophys Acta (2004) 0.91
Photochemical and electrophysical production of radicals on millisecond timescales to probe the structure, dynamics and interactions of proteins. Photochem Photobiol Sci (2004) 0.89
OncoCis: annotation of cis-regulatory mutations in cancer. Genome Biol (2014) 0.89
Subtyping of the influenza virus by high resolution mass spectrometry. Anal Chem (2009) 0.87
Mitochondrial metabolism inhibitors for cancer therapy. Pharm Res (2011) 0.87
Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains. Biochem J (2011) 0.86
Reduced monomeric CD4 is the preferred receptor for HIV. J Biol Chem (2010) 0.86
Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains. J Natl Cancer Inst (2005) 0.86
Plasmin reduction by phosphoglycerate kinase is a thiol-independent process. J Biol Chem (2002) 0.85
Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloid. Int J Biochem Cell Biol (2007) 0.84
Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acid. J Biol Chem (2008) 0.83
Signature peptides of influenza nucleoprotein for the typing and subtyping of the virus by high resolution mass spectrometry. Analyst (2009) 0.83
Typing of human and animal strains of influenza virus with conserved signature peptides of matrix M1 protein by high resolution mass spectrometry. J Virol Methods (2010) 0.83
Allosteric control of βII-tryptase by a redox active disulfide bond. J Biol Chem (2013) 0.83
Characterization of redox-active proteins on cell surface. Methods Enzymol (2002) 0.82
Rapid typing and subtyping of vaccine strains of the influenza virus with high resolution mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) (2010) 0.82
Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36. Thromb Res (2003) 0.82
Rapid differentiation of seasonal and pandemic H1N1 influenza through proteotyping of viral neuraminidase with mass spectrometry. Anal Chem (2010) 0.80
Optical imaging of treatment-related tumor cell death using a heat shock protein-90 alkylator. Mol Pharm (2013) 0.80
Bioinformatics analysis reveals biophysical and evolutionary insights into the 3-nitrotyrosine post-translational modification in the human proteome. Open Biol (2013) 0.80
Mechanism of dimerization of a recombinant mature vascular endothelial growth factor C. Biochemistry (2013) 0.80
Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation. J Biol Chem (2013) 0.78
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function. Biochem J (2010) 0.78
Signal analysis for genome-wide maps of histone modifications measured by ChIP-seq. Bioinformatics (2012) 0.78
Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas. Genes Chromosomes Cancer (2015) 0.77
Employing pancreatic tumor γ-glutamyltransferase for therapeutic delivery. Mol Pharm (2014) 0.77
Measurement of reduction of disulfide bonds in plasmin by phosphoglycerate kinase. Methods Enzymol (2002) 0.76
Tyrosine nitration moderates the peptidase activity of human methionyl aminopeptidase 2. Biochem Biophys Res Commun (2013) 0.76
Disulfide exchange in CD4. Biofactors (2003) 0.75
Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodies. BMC Cancer (2006) 0.75
A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura. Eur J Haematol (2003) 0.75
Novel and emerging therapies in cardiology and haematology. Curr Drug Targets Cardiovasc Haematol Disord (2003) 0.75
Selective targeting of mitochondria for the treatment of cancer. Discov Med (2005) 0.75
Bioorthogonal labelling of 3-nitrotyrosine in peptides and proteins through diazotisation mediated azidation. Org Biomol Chem (2014) 0.75
Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing. J Pharm Pharmacol (2013) 0.75
Mass trees: a new phylogenetic approach and algorithm to chart evolutionary history with mass spectrometry. Anal Chem (2013) 0.75
Identification of redox-active proteins on cell surface. Methods Enzymol (2002) 0.75